Biotech

All Articles

ArsenalBio increases $325M, rotates off of previous lead possession

.Toolbox Biosciences is carrying on up. The cell therapy provider has actually added on $325 thousan...

Lilly- backed weight-loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' marijuana make use of medicine flunks phase 2b, steering Indivior to reassess $100M alternative

.Aelis Farma's hopes of protecting a simple, beneficial decision on a $one hundred thousand alternat...

ProKidney standstills phase 3 test not required for cell treatment confirmation

.ProKidney has actually ceased some of a set of stage 3 tests for its tissue therapy for renal disea...

Vaxcyte climbs on 'spectacular' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what analysts called "remarkable" stage 1/2 data for its own 31-valent pneumococ...

Recursion's human brain disease trial shows little documentation of efficacy

.Recursion has discovered by means of a very early test of its own tech-enabled method to drug explo...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Contact it a situation of really good chemical make up: Acepodia, a biotech based on Nobel Champion...

Praxis epilepsy drug reduces confiscations in period 2 hearing

.Practice Preciseness Medicines has scored yet another midphase win in epilepsy this year, with its ...

Three execs surrender as Dyne messages blended data for DMD applicant

.After getting away from a medical grip a number of years back, Dyne Rehab has exposed new period 1/...

Arrowhead fires off period 3 records in unusual metabolic illness before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its hand ahead of a prospective face-off along with Ionis, ...